Sunday, May 17, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Trends

Modern Day Fertility Crisis

Daily Remedy by Daily Remedy
October 3, 2021
in Trends
0

Strategy is limited by capability. We can only do what are able to do.

Choice sometimes becomes a matter of necessity, depending on the number of available options. When the options are limited, the perception of choice is often nothing more than an illusion.

A recent report from the National Bureau of Economic Research (NBER) concludes that the dramatic decrease in fertility rates over the past fifteen years in the United States is a matter of choice – or as the authors write, a matter of shifting priorities.

That more Americans prefer to have children later in life or to prioritize other aspects of their life, such as their career, instead of rearing children at ages comparable to previous generations.

But choice is a matter of perspective, and the authors fail to understand the complex impact of societal changes that may force many to defer childbirth.

The authors examine the role of choice relative to societal and economic constraints over time, noting the declining fertility rate to correspond mostly with changing expectations of parenting in younger Americans. They find the shift to reflect broad societal changes that are difficult to measure, and they oddly refrain from discussing whether declining fertility rates are good or bad.

One on hand, they state lower fertility rates will create additional burdens through social security and other age related welfare programs. But then they presume that lower fertility rates lead to greater economic empowerment among women – creating a specious inverse correlation between fertility and women’s rights.

But fertility does not vary inversely with women’s rights, and to correlate the two imposes limitations on society’s views of women.

Some women may want to raise children, and some may not. Some women may want to prioritize their career, and some may be able to have children while doing so but some may not. The notion of choice is flawed because the correlation between choice and economic empowerment is convoluted at best.

Economic reports that attempt to integrate subjective perceptions with economic projections often fail to identify any meaningful conclusion because perceptions are not mutually exclusive from economic trends.

For example, while the authors analyzed multiple economic determinants as a function of changing fertility rates, many of these determinants were financial in nature. In one analysis, the authors found no correlation between student debt and fertility rates. But in another analysis, they found a strong correlation of increasing unemployment with decreasing fertility rates.

Both student debt and unemployment rates are financial pressures. And the authors characterize both as such. But they fail to explain why one form of financial pressure impacts fertility rates while the other does not. Nor do they correlate either in terms of choice or economic empowerment.

Conceivably, student debt would correlate with greater economic empowerment. Women must choose to go to college. Those who go to college are generally more intelligent and independent in their thinking.

Those who are unemployed are seen as less educated and – following the same trend of loose generalizations – less empowered.

If the authors conclude that women are more empowered and therefore choosing to have fewer children, then they base their conclusion less on data itself, and more on their perceptions of data.

The study found only three factors correlating with lower fertility rates – unemployment rate, maximum welfare benefits, and the option to pursue a Medicaid family planning expansion waiver. But none of the three could explain the full extent of the decreasing rate.

So the authors attribute the discrepancy to choice – postulating that since no tangible economic metric can explain the full rate of decline, personal choice must be the determining factor.

This type of analysis is both lazy and dangerous, leading to broad generalizations that do not reflect the actual impact of societal changes on fertility rates.

The main conclusion we should draw from this report is that there is no obvious conclusion. There is no definitive perception or economic factor examined in the report that accounts for declining fertility rates.

The issue is more complicated than our current understanding.

The authors should have concluded the trends in fertility rates are more complex than the study design allows for, instead of drawing convenient conclusions out of poorly correlating data.

But that would have required the authors admitting to a faulty study design.

That is a choice the authors did not make.

ShareTweet
Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

summary

An in-depth exploration of drug pricing, including key databases like NADAC, WAC, and ASP, and how they influence the pharmaceutical supply chain, policy, and patient advocacy. The episode also introduces MedPricer's innovative pricing intelligence platform, offering valuable insights for healthcare professionals, policymakers, and patients.

Chapters

00:00 Understanding Drug Pricing Dynamics
03:52 Exploring the Drug Pricing Database
10:07 Patient Advocacy and Drug Pricing
13:56 Market Intelligence in Drug Pricing
How NADAC, WAC, and ASP Shape Drug CostsDaily Remedy
YouTube Video X-Tfwy7XKEg
Subscribe

Policy Shift in Peptide Regulation

Clinical Reads

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

by Daily Remedy
April 19, 2026
0

Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • The 340B Coalition

    The 340B Coalition

    0 shares
    Share 0 Tweet 0
  • One Dose, Many Decades

    0 shares
    Share 0 Tweet 0
  • The Cardiometabolic Sprawl

    0 shares
    Share 0 Tweet 0
  • The Biosimilar That Wouldn’t

    0 shares
    Share 0 Tweet 0
  • Force of Impact in a Tackle

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy